PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

被引：211

作者：

Fendler, Wolfgang P. ^{[1
,2
]}

Eiber, Matthias ^{[3
]}

Beheshti, Mohsen ^{[4
]}

Bomanji, Jamshed ^{[5
]}

Calais, Jeremie ^{[6
]}

Ceci, Francesco ^{[7
,8
]}

Cho, Steve Y. ^{[9
]}

Fanti, Stefano ^{[10
]}

Giesel, Frederik L. ^{[11
,12
]}

Goffin, Karolien ^{[13
]}

Haberkorn, Uwe ^{[12
]}

Jacene, Heather ^{[14
]}

Koo, Phillip J. ^{[15
]}

Kopka, Klaus ^{[16
,17
,18
]}

Krause, Bernd J. ^{[19
]}

Lindenberg, Liza ^{[20
]}

Marcus, Charles ^{[21
]}

Mottaghy, Felix M. ^{[22
,23
]}

Oprea-Lager, Daniela E. ^{[24
]}

Osborne, Joseph R. ^{[25
]}

Piert, Morand ^{[26
]}

Rowe, Steven P. ^{[27
]}

Schoeder, Heiko ^{[28
]}

Wan, Simon ^{[5
]}

Wester, Hans-Jurgen ^{[29
]}

Hope, Thomas A. ^{[30
]}

Herrmann, Ken ^{[1
]}

机构：

[1] Univ Duisburg Essen & German Canc Consortium DKTK, Dept Nucl Med, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany

[2] PET Comm German Soc Nucl Med, Marburg, Germany

[3] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany

[4] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Nucl Med, Div Mol Imaging & Theranost, Salzburg, Austria

[5] UCLH NHS Fdn Trust, Inst Nucl Med, London, England

[6] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA USA

[7] IEO European Inst Oncol, Div Nucl Med & Theranost, IRCCS, Milan, Italy

[8] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[9] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA

[10] AOU Bologna, IRCCS, Bologna, Italy

[11] Heinrich Heine Univ, Dept Nucl Med, Univ Hosp Dusseldorf, Med Fac, Heidelberg, Germany

[12] Univ Hosp Heidelberg, Dept Nucl Med, Heidelberg, Germany

[13] Katholieke Univ Leuven, Dept Nucl Med, Div Nucl Med & Mol Imaging, Univ Hosp Leuven, Louvain, Belgium

[14] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

[15] Banner MD Anderson Canc Ctr, Phoenix, AZ USA

[16] Helmholtz Zentrum Dresden Rossendorf HZDR, Inst Radiopharmaceut Canc Res, Dresden, Germany

[17] Tech Univ Dresden, Fac Chem & Food Chem, Sch Sci, Dresden, Germany

[18] German Canc Consortium DKTK, Partner Site Dresden, Dresden, Germany

[19] Univ Rostock, Univ Med Ctr, Dept Nucl Med, Rostock, Germany

[20] NCI, NIH, Mol Imaging Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[21] Emory Univ, Sch Med, Dept Radiol, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA

[22] Univ Hosp RWTH Aachen Univ, Dept Nucl Med, Aachen, Germany

[23] Maastricht Univ Med Ctr MUMC, Dept Radiol & Nucl Med, Maastricht, Netherlands

[24] Univ Amsterdam, VU Univ Med Ctr, Canc Ctr Amsterdam, Dept Radiol & Nucl Med,Med Ctr, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

[25] Weill Cornell Med, Div Mol Imaging & Therapeut, Dept Radiol, New York, NY USA

[26] Univ Michigan, Dept Radiol, Div Nucl Med & Mol Imaging, Ann Arbor, MI 48109 USA

[27] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Nucl Med & Mol Imaging, Baltimore, MD USA

[28] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[29] Tech Univ Munich, Pharmaceut Radiochem, Walther Meissner Str 3, D-85748 Garching, Germany

[30] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / 05期

关键词：

PSMA; PET; Prostate cancer; Staging; Restaging; Guideline; MEMBRANE ANTIGEN PSMA; LU-177-PSMA-617 RADIOLIGAND THERAPY; RADIATION-DOSIMETRY; BIOCHEMICAL RECURRENCE; GA-68-PSMA PET/CT; F-18-DCFPYL PET/CT; EXPRESSION; BIODISTRIBUTION; DIAGNOSIS; RECOMMENDATIONS;

D O I：

10.1007/s00259-022-06089-w

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/ CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.

引用

页码：1466 / 1486

页数：21

共 146 条

[1]

ACR Manual On Contrast Media, 2021, ACR COMM DRUGS CONTR

[2] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions [J].

Afshar-Oromieh, A. ;

Malcher, A. ;

Eder, M. ;

Eisenhut, M. ;

Linhart, H. G. ;

Hadaschik, B. A. ;

Holland-Letz, T. ;

Giesel, F. L. ;

Kratochwil, C. ;

Haufe, S. ;

Haberkorn, U. ;

Zechmann, C. M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) :486-495

[3] Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer [J].

Afshar-Oromieh, Ali ;

Debus, Nils ;

Uhrig, Monika ;

Hope, Thomas A. ;

Evans, Michael J. ;

Holland-Letz, Tim ;

Giesel, Frederik L. ;

Kopka, Klaus ;

Hadaschik, Boris ;

Kratochwil, Clemens ;

Haberkorn, Uwe .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (12) :2045-2054

[4] The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions [J].

Afshar-Oromieh, Ali ;

Hetzheim, Henrik ;

Kratochwil, Clemens ;

Benesova, Martina ;

Eder, Matthias ;

Neels, Oliver C. ;

Eisenhut, Michael ;

Kuebler, Wolfgang ;

Holland-Letz, Tim ;

Giesel, Frederik L. ;

Mier, Walter ;

Kopka, Klaus ;

Haberkorn, Uwe .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) :1697-1705

[5] Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer [J].

Aggarwal, Rahul ;

Wei, Xiao ;

Kim, Won ;

Small, Eric J. ;

Ryan, Charles J. ;

Carroll, Peter ;

Cooperberg, Matthew ;

Evans, Michael J. ;

Hope, Thomas .

EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (01) :78-82

[6] 68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept [J].

Ahmadzadehfar, Hojjat ;

Azgomi, Kambiz ;

Hauser, Stefan ;

Wei, Xiao ;

Yordanova, Anna ;

Gaertner, Florian C. ;

Kuerpig, Stefan ;

Strunk, Holger ;

Essler, Markus .

JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) :438-444

[7]

[Anonymous], ABOUT US

[8]

[Anonymous], FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

[9]

[Anonymous], FDA approves second PSMA-targeted PET imaging drug for men with prostate cancer

[10]

[Anonymous], AUSTR TGA APPROVES I

← 1 2 3 4 5 6 7 8 9 10 →